PharmaCell B.V. appoints new CEO

03-Nov-2009 - Netherlands

PharmaCell B.V. has appointed Mr. Alexander Vos as Chief Executive Officer, effective November 1st 2009. Mr. Vos has 20 years of leadership experience in the pharma and biotech industry. He joins from PAION AG, where he was a Member of the Management Board (“Vorstand”) and Chief Operating Officer from 2004 onwards.

Mr. Vos started his career at McKinsey & Co. as a strategy consultant in their international pharmaceutical practice. Subsequently, at Genzyme Therapeutics Europe he held executive positions as European Marketing Director and Director of Business Development, before assuming global responsibility for its joint venture with Pharming N.V. From 2000 to 2004, Mr. Vos served as Chief Executive Officer of MediService AG (Switzerland), a specialty pharmacy service companies in Europe, which was successfully sold to Galenica AG. Mr. Vos holds a M.Sc. in Pharmacy and Pharmacology from the University of Amsterdam and an MBA from the Stanford Graduate School of Business.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances